USING ARTIFICIAL NEURAL NETWORKS FOR PREDICTING NEW BILHARZIA CASES IN CHILDREN AGED 15 YEARS AND BELOW AT GWERU PROVINCIAL HOSPITAL IN ZIMBABWE

Authors

  • DR. SMARTSON. P. NYONI
  • MR. THABANI NYONI

Keywords:

children, infection, study, area

Abstract

Bilharzia is an important, and yet neglected, infectious disease affecting at least 100 million people in Africa. Children in Zimbabwe, just like other children of Africa, continue to carry the heaviest burden of infection, with children as young as 12 months old showing signs of infection. This paper uses monthly time series data on bilharzia cases recorded and managed at Gweru Provincial Hospital (GPH) from Janaury 2010 to December 2019, in order to make predictions over the period January 2020 to December 2021. The study employed the famous ANN (12, 12, 1) model. Residual analysis of this model showed that the model is stable and thus suitable for predicting bilharzia cases at GPH over the out-of-sample period. The findings of this study indicate that bilharzia cases will continue on an upwards trajectory within the GPH catchment area. The study, amongst other policy directions; recommends prompt administration of antiparasite treatment (that is, praziquantel (PZQ)) to all infected children.

Downloads

Published

2021-01-22

Issue

Vol. 7 No. 09 (2020): IJIERT

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0 DEED).

You are free to:

  1. Share — copy and redistribute the material in any medium or format
  2. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. NonCommercial — You may not use the material for commercial purposes .
  3. NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
  4. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

 

Rights of Authors

Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.